4LITETier 7
Harris Isaac Hosojiro received vested RSU awards in Lumentum Holdings Inc. common stock on three dates in 2026 with shares withheld to cover taxes, resulting in modest net increases to his direct holdings.
Lumentum Holdings Inc. · CIK 1633978 · 0001866503-26-000006
EDGAR4WDAYTier 7
Gerrit S. Kazmaier, President, Product and Technology of Workday, Inc., had shares withheld for taxes on RSU vesting and then sold 2,728 shares of Class A Common Stock under a Rule 10b5-1 plan, modestly trimming his holdings.
Workday, Inc. · CIK 1327811 · 0002060774-26-000013
EDGAR4WDAYTier 8
Workday CFO Zane Rowe had 7,953 shares withheld for taxes on RSU vesting and sold a total of 6,000 shares of Class A Common Stock under a Rule 10b5-1 plan, leaving 288,460 shares owned directly plus substantial unvested equity awards.
Workday, Inc. · CIK 1327811 · 0001444158-26-000016
EDGAR4NETTier 6
John Graham-Cumming exercised 2,520 Cloudflare (NET) stock options at $44.72 and sold 2,520 Class A shares around $245–$250 under a 10b5-1 plan, retaining 494,909 shares.
Cloudflare, Inc. · CIK 1477333 · 0002062725-26-000016
EDGAR4ROKUTier 6
Charles Collier, President, Roku Media at Roku, Inc., exercised 20,538 stock options at $49.59 and sold 20,538 Class A shares around $142.5 per share under a 10b5-1 plan, ending with 15,200 shares owned.
ROKU, INC · CIK 1428439 · 0001951665-26-000018
EDGAR4XERSTier 6
CFO Steven Pieper sold a total of 45,000 shares of Xeris Biopharma Holdings, Inc. common stock for roughly $383,000 under a Rule 10b5-1 plan.
Xeris Biopharma Holdings, Inc. · CIK 1867096 · 0001875714-26-000007
EDGAR4WDAYTier 6
Workday CAO Mark S. Garfield had 3,490 shares of Class A Common Stock withheld for taxes upon RSU vesting, leaving him with 74,636 shares (including 64,944 RSUs).
Workday, Inc. · CIK 1327811 · 0001602315-26-000014
EDGAR4WDAYTier 7
Workday CEO Aneel Bhusri had 8,501 Class A shares withheld on July 5, 2026 to cover taxes on vested RSUs, a routine compensation-related transaction, and remains a very large shareholder.
Workday, Inc. · CIK 1327811 · 0001196579-26-000012
EDGAR4WDAYTier 8
Robert Enslin, President and CCO of Workday, Inc., had 5,634 shares withheld for taxes upon RSU vesting and sold 5,374 shares of Class A Common Stock under a Rule 10b5-1 plan on July 5, 2026, leaving ownership of 239,469 shares.
Workday, Inc. · CIK 1327811 · 0001928908-26-000013
EDGAR4WDAYTier 9
David A. Duffield converted 107,500 Class B shares into Class A and sold 108,000 Class A shares of Workday, Inc. (WDAY) on July 6, 2026 for about $14.5 million under a Rule 10b5‑1 plan.
Workday, Inc. · CIK 1327811 · 0000938071-26-000044
EDGAR4WDAYTier 7
Workday Chief Legal Officer & Secretary Richard Harry Sauer had 6,782 shares of Class A Common Stock withheld for taxes upon RSU vesting, leaving him with 174,743 shares beneficially owned.
Workday, Inc. · CIK 1327811 · 0001787944-26-000011
EDGAR8KTier 7
Beneficient amended and restated its standby equity purchase agreement with YA II PN, Ltd. to a $100 million equity facility including a $4 million pre-paid convertible note advance, extending its equity financing arrangement under revised terms and limits.
Beneficient · CIK 1775734 · 0001493152-26-032323
EDGAR4INCYTier 5
CEO and President William Meury had 4,779 Incyte common shares withheld for taxes upon RSU/performance share settlement, leaving him with 156,322 shares.
INCYTE CORP · CIK 879169 · 0001536778-26-000007
EDGAR4INCYTier 4
Steven H. Stein had 2,177 Incyte Corp common shares withheld for taxes upon RSU/performance share settlement, leaving him with 76,150 directly owned shares.
INCYTE CORP · CIK 879169 · 0001673776-26-000015
EDGAR8KTier 7
BIO-key International regained compliance with Nasdaq listing standards, leading to the resumption of trading of its common stock on the Nasdaq Capital Market effective July 8, 2026, subject to a one-year monitoring period.
BIO KEY INTERNATIONAL INC · CIK 1019034 · 0001437749-26-022880
EDGAR8KTier 6
Capstone Energy+ announced that its common stock will transfer from OTCQX to the Nasdaq Global Select Market and begin trading under the ticker CEPL on July 8, 2026, marking a key milestone in its strategic and financial transformation.
Capstone Energy Plus, Inc. · CIK 1009759 · 0001104659-26-080974
EDGAR8KTier 5
Zapata Quantum disclosed that its CEO will present at a July 9, 2026 virtual investor conference and highlighted recent strategic achievements including an NVIDIA collaboration, award-winning quantum drug discovery research, a $15 million fundraise, and leadership expansion.
Zapata Quantum, Inc. · CIK 1843714 · 0001683168-26-005316
EDGAR8KTier 8
Envirotech Vehicles (EVTV) closed its merger with Azio AI on July 2, 2026, simultaneously pivoting into AI infrastructure and implementing a new leadership team including Chris Young as CEO and Simon Yu as President.
Envirotech Vehicles, Inc. · CIK 1563568 · 0001437749-26-022877
EDGAR8KMGTXTier 7
MeiraGTx Holdings plc entered into a private Securities Purchase Agreement with TPC-affiliated funds to sell about $10 million of ordinary shares and grant them rights to buy up to roughly $15 million more shares and to participate in future equity financings, in connection with a contemporaneous Note Purchase Agreement.
MeiraGTx Holdings plc · CIK 1735438 · 0001104659-26-080949
EDGAR4NETTier 7
CEO & Board Co‑Chair Matthew Prince converted Class B into Class A shares of Cloudflare, Inc. and sold about 94.7K Class A shares in open‑market transactions totaling roughly $23.7 million between July 2 and July 6, 2026 under a Rule 10b5‑1 plan.
Cloudflare, Inc. · CIK 1477333 · 0001786925-26-000029
EDGAR4NETTier 7
Cloudflare CEO & Board Co‑Chair Matthew Prince converted Class B to Class A shares and sold approximately 68,000 Class A shares of Cloudflare, Inc. around $240–$252 per share via Rule 10b5‑1 trades on July 1–2, 2026 through various trusts.
Cloudflare, Inc. · CIK 1477333 · 0001786925-26-000027
EDGAR4IONSTier 5
Non-employee director Michael J. Yang received stock options for 5,369 shares at $79.19 and 2,301 RSUs of Ionis Pharmaceuticals, Inc. common stock as part of routine director equity compensation.
IONIS PHARMACEUTICALS INC · CIK 874015 · 0000874015-26-000232
EDGAR4IONSTier 5
Director Joseph Loscalzo received stock options for 5,369 shares at $79.19 and 2,301 RSUs in Ionis Pharmaceuticals as part of routine non-employee director compensation.
IONIS PHARMACEUTICALS INC · CIK 874015 · 0000874015-26-000231
EDGAR4IONSTier 6
Director Joseph Klein III of Ionis Pharmaceuticals Inc. exercised 11,518 stock options, sold 11,518 common shares for roughly $0.9 million, and received new option and RSU grants totaling 7,670 shares.
IONIS PHARMACEUTICALS INC · CIK 874015 · 0000874015-26-000229
EDGAR4IONSTier 5
Non-employee director Michael R. Hayden received stock options for 5,369 shares at $79.19 and 2,301 RSUs of Ionis Pharmaceuticals on July 1, 2026 as part of his annual equity compensation.
IONIS PHARMACEUTICALS INC · CIK 874015 · 0000874015-26-000228
EDGAR4IONSTier 5
Director Spencer R. Berthelsen received a stock option grant for 5,369 shares at $79.19 and an award of 2,301 RSUs in Ionis Pharmaceuticals, Inc. as part of routine director compensation.
IONIS PHARMACEUTICALS INC · CIK 874015 · 0000874015-26-000226
EDGAR4JAZZTier 7
Bruce C. Cozadd sold 6,000 Ordinary Shares of Jazz Pharmaceuticals plc at about $240.47 per share under a Rule 10b5‑1 plan.
Jazz Pharmaceuticals plc · CIK 1232524 · 0001193210-26-000016
EDGAR4DDOGTier 7
Non-employee director Dominic Phillips received an equity award of 48 shares of Datadog, Inc. Class A Common Stock in lieu of cash compensation.
Datadog, Inc. · CIK 1561550 · 0001561550-26-000235
EDGAR4ZYMETier 4
EVP & COO Mark Hollywood acquired 939 shares of Zymeworks Inc. common stock via ESPP at $22.22 per share on 2026-07-06.
Zymeworks Inc. · CIK 1937653 · 0002104446-26-000009
EDGAR8KPRGOTier 7
Perrigo has appointed Albert Manzone as Interim President and CEO under a fixed‑term contract with specified compensation, equity, and termination terms.
PERRIGO Co plc · CIK 1585364 · 0001585364-26-000110
EDGAR4MCHPTier 7
COO Richard J. Simoncic received 3,523 restricted stock units and 3,524 performance stock units of Microchip Technology Inc. common stock as equity awards.
MICROCHIP TECHNOLOGY INC · CIK 827054 · 0001181945-26-000022
EDGAR4MCHPTier 7
Steve Sanghi, President, CEO and Chair of Microchip Technology Inc. (MCHP), was granted 14,658 RSUs and 21,986 PSUs tied to future performance on July 1, 2026.
MICROCHIP TECHNOLOGY INC · CIK 827054 · 0001181928-26-000028
EDGAR4VTier 6
Visa Inc. General Counsel Julie B. Rottenberg exercised options and sold roughly 20.7K shares of Visa Class A Common Stock on July 2, 2026 under a Rule 10b5‑1 plan, ending with 18.4K shares owned directly.
VISA INC. · CIK 1403161 · 0001403161-26-000090
EDGAR4ZLABTier 6
Insider Richard Gaynor bought 1,736 American Depositary Shares of Zai Lab Ltd at about $19.05 per ADS, bringing his direct holdings to 80,737 ADSs.
Zai Lab Ltd · CIK 1704292 · 0000905148-26-003169
EDGAR4ZLABTier 5
Du Ying, Chairperson & CEO of Zai Lab Ltd, had RSUs vest into ADSs with shares withheld for taxes and received a new RSU grant totaling 80,393 units, with no open‑market buys or sells.
Zai Lab Ltd · CIK 1704292 · 0000905148-26-003167
EDGAR8KTier 7
Ashford Hospitality Trust, Inc. sold the Hyatt Regency Savannah for approximately $157.6 million in cash and repaid related mortgage debt, providing unaudited pro forma financials to reflect the hotel’s disposition and associated non-recurring gain.
ASHFORD HOSPITALITY TRUST INC · CIK 1232582 · 0001232582-26-000160
EDGAR8KINCYTier 8
Incyte completed its $1.25 billion-plus milestone acquisition of Vega Therapeutics, gaining Phase 3 asset VGA039 for von Willebrand disease and recording the deal as a one-time R&D expense in 2026.
INCYTE CORP · CIK 879169 · 0000879169-26-000048
EDGAR4ABSITier 7
Director Mary T. Szela bought 12,900 shares of Absci Corp (ABSI) common stock on the open market at $11.54 per share, bringing her holdings to 21,300 shares.
Absci Corp · CIK 1672688 · 0001672688-26-000124
EDGAR4PROKTier 6
Chief Technical Officer Kenneth Thomas Locke received an employee stock option award for 750,000 shares of ProKidney Corp. Class A Common Stock at an exercise price of $1.89 per share.
PROKIDNEY CORP. · CIK 1850270 · 0001193125-26-296160
EDGAR4RARETier 6
CFO Howard Horn sold 4,698 shares of Ultragenyx Pharmaceutical Inc. common stock at $33.13 per share and now holds 100,991 shares directly.
Ultragenyx Pharmaceutical Inc. · CIK 1515673 · 0001193125-26-296128
EDGAR4NBISTier 8
Nebius Group N.V. CTO Danila Shtan sold 16,937 Class A Shares at about $235.45 per share (~$3.99M) in an automatic tax-withholding sale following RSU vesting.
Nebius Group N.V. · CIK 1513845 · 0001513845-26-000078
EDGAR4VZTier 5
Alfonso Villanueva Rodriguez received 87.222 units of Verizon Communications Inc. phantom stock via a deferred compensation plan, bringing his indirect phantom holdings to 6,576.226 units.
VERIZON COMMUNICATIONS INC · CIK 732712 · 0002111103-26-000025
EDGAR4VZTier 5
Vandana Venkatesh, EVP and Chief Legal Officer of Verizon, was awarded 106.463 phantom stock units under a deferred compensation plan, increasing her indirect holdings to about 56,708 units.
VERIZON COMMUNICATIONS INC · CIK 732712 · 0001950027-26-000036
EDGAR4VZTier 4
Mary‑Lee Stillwell, SVP and Controller of Verizon Communications Inc. (VZ), acquired 48.742 phantom stock units via the deferred compensation plan, bringing her total phantom holdings to 16,680.794 units.
VERIZON COMMUNICATIONS INC · CIK 732712 · 0001750052-26-000036
EDGAR4VZTier 5
EVP and Group CEO–VZ Business Kyle Malady received an award of 144.943 phantom stock units tied to Verizon Communications Inc. common stock through the company’s deferred compensation plan.
VERIZON COMMUNICATIONS INC · CIK 732712 · 0001760581-26-000036
EDGAR4VZTier 5
Verizon EVP and CFO Anthony T. Skiadas received 144.943 units of phantom stock linked to Verizon common stock through the company’s deferred compensation plan.
VERIZON COMMUNICATIONS INC · CIK 732712 · 0001578926-26-000034
EDGAR4VZTier 4
EVP & Chief HR Officer Samantha Hammock received additional phantom stock units under Verizon’s deferred compensation plan on July 1, 2026.
VERIZON COMMUNICATIONS INC · CIK 732712 · 0001896468-26-000038
EDGAR4VZTier 4
Joseph J. Russo, EVP & Pres–Global Networks & Tech of Verizon, was awarded 92.033 phantom stock units under a deferred compensation plan, bringing his indirect phantom holdings to 83,309.114 units.
VERIZON COMMUNICATIONS INC · CIK 732712 · 0001968243-26-000038
EDGAR4VZTier 4
Verizon CEO Daniel H. Schulman received 221.905 units of cash-settled phantom stock under a deferred compensation plan.
VERIZON COMMUNICATIONS INC · CIK 732712 · 0001215315-26-000030
EDGAR4NBISTier 9
Chief Infrastructure Officer Andrey Korolenko sold 33,871 Nebius Group N.V. Class A Shares at about $235.45 per share in an automatic sale to cover RSU-related taxes.
Nebius Group N.V. · CIK 1513845 · 0001513845-26-000076
EDGAR
